KEY
29
-2
CI
33
-3
IFF
48
-2
WY
45
-3
ROK
54
2
TMO
54
-2
NI
65
-2
XYL
35
-6
GIS
37
3
HIG
48
-6
DAL
58
-6
DD
53
-2
OMC
35
-4
PYPL
60
-2
NUE
43
-4
IP
57
3
TROW
48
-6
PDCO
77
2
HAL
39
-2
KO
46
4
KEY
29
-2
CI
33
-3
IFF
48
-2
WY
45
-3
ROK
54
2
TMO
54
-2
NI
65
-2
XYL
35
-6
GIS
37
3
HIG
48
-6
DAL
58
-6
DD
53
-2
OMC
35
-4
PYPL
60
-2
NUE
43
-4
IP
57
3
TROW
48
-6
PDCO
77
2
HAL
39
-2
KO
46
4
Financhill
Back

Genscript Biotech 10K Form

Buy
65

GNNSF
Genscript Biotech

Last Price:
1.25
Seasonality Move:
-4.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GNNSF News And Ratings

See the #1 stock for the next 7 days that we like better than GNNSF

GNNSF Financial Statistics

Sales & Book Value

Annual Sales: $839.53M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.57
Price / Book: 2.21

Profitability

EPS (TTM): -0.08360
Net Income (TTM): $-177.01M
Gross Margin: $409.55M
Return on Equity: -8.92%
Return on Assets: -5.26%

Genscript Biotech Earnings Forecast

Key Genscript Biotech Financial Ratios

  • The Gross Profit Margin over the past 10 years for GNNSF is 48.78%.
  • The Selling, General & Administrative Expenses for GNNSF have been equal to 46.19% of Gross Profit Margin.
  • The Research & Development expenses have been 51.56% of Revenue.
  • The Interest Expense is -28.81% of Operating Income.
  • The Net Earning history of GNNSF is -11.37% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 4 years.

Genscript Biotech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: GNNSF
Website: genscript.com

Debt

Debt-to-Equity Ratio: 0.28
Current Ratio: 4.15
Quick Ratio: 3.96

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GNNSF Technical Analysis vs Fundamental Analysis

Buy
65
Genscript Biotech (GNNSF) is a Buy

Is Genscript Biotech a Buy or a Sell?